0000950170-24-030331.txt : 20240312
0000950170-24-030331.hdr.sgml : 20240312
20240312202420
ACCESSION NUMBER: 0000950170-24-030331
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240311
FILED AS OF DATE: 20240312
DATE AS OF CHANGE: 20240312
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KURIYEL RALF
CENTRAL INDEX KEY: 0001733143
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14656
FILM NUMBER: 24744220
MAIL ADDRESS:
STREET 1: 41 SEYON ST
STREET 2: BLDG 1, STE. 100
CITY: WALTHAM
STATE: MA
ZIP: 02452
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REPLIGEN CORP
CENTRAL INDEX KEY: 0000730272
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 042729386
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 7814499560
MAIL ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
4
1
ownership.xml
4
X0508
4
2024-03-11
0000730272
REPLIGEN CORP
RGEN
0001733143
KURIYEL RALF
C/O REPLIGEN CORPORATION
41 SEYON ST., BLDG 1, STE 100
WALTHAM
MA
02453
false
true
false
false
Senior VP, R&D
false
Common Stock
2024-03-11
4
M
false
1271
86.10
A
27777
D
Common Stock
2024-03-11
4
S
false
3517
193.73
D
24260
D
Stock Option (Right to Buy)
86.10
2024-03-11
4
M
false
1271
0.00
A
2030-02-27
Common Stock
1271
0
D
$193.73 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.64 to $194.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
This option is fully vested and exercisable.
/s/ Kimberly Brown (Attorney in Fact)
2024-03-12